Healthcare - Biotechnology - NASDAQ - US
$ 0.7343
-5.77 %
$ 105 M
Market Cap
-1.18
P/E
BALANCE SHEET
298 M
ASSETS
26.6 M
LIABILITIES
272 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Quantum-Si incorporated
| Current Assets | 266 M |
| Cash & Short-Term Investments | 258 M |
| Receivables | 368 K |
| Other Current Assets | 8.21 M |
| Non-Current Assets | 31.9 M |
| Long-Term Investments | 0 |
| PP&E | 30.7 M |
| Other Non-Current Assets | 1.23 M |
| Current Liabilities | 11.6 M |
| Accounts Payable | 1.77 M |
| Short-Term Debt | 3.13 M |
| Other Current Liabilities | 6.71 M |
| Non-Current Liabilities | 15 M |
| Long-Term Debt | 13.7 M |
| Other Non-Current Liabilities | 1.28 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 133.9 | 84.3 | 35.8 | 36.9 | 32.9 |
| Short Term Investments | 123.9 | 267.0 | 435.5 | 0 | 0 |
| Receivables | 0.4 | 0 | 0 | 0 | 0 |
| Inventory | 3.9 | (0.2) | (0.9) | 0 | 0 |
| Other Current Assets | 4.3 | 6.9 | 5.0 | 0.4 | 0.9 |
| Total Current Assets | 266.3 | 358.2 | 477.2 | 37.9 | 33.9 |
| PP&E | 30.7 | 32.6 | 15.9 | 2.0 | 2.6 |
| Intangible Assets | 0.5 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 9.5 | 0 | 0 |
| Long Term Investments | 0 | 0 | (2.4) | 0 | 0 |
| Other Long Term Assets | 0.7 | (3.9) | 0.7 | 0.6 | 1.0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 298.2 | 391.5 | 503.2 | 40.6 | 37.4 |
| LIABILITIES | |||||
| Accounts Payable | 1.8 | 3.9 | 3.4 | 1.3 | 0.9 |
| Short Term Debt | 3.1 | 2.7 | 1.7 | 0 | 0 |
| Other Current Liabilities | 6.7 | 9.1 | 6.4 | 1.4 | 1.1 |
| Total Current Liabilities | 11.6 | 15.7 | 11.5 | 2.8 | 1.9 |
| Long Term Debt | 13.7 | 16.1 | 7.2 | 1.7 | 0 |
| Deferred Tax Income | 0 | 4.6 | 2.4 | 0.2 | 0 |
| Other Liabilities | 1.3 | 1.0 | 7.4 | 0 | 0 |
| Total Liabilities | 26.6 | 32.8 | 26.2 | 4.5 | 1.9 |
| EQUITY | |||||
| Common Stock | 14 K | 14 K | 14 K | 1 K | 1 K |
| Retained Earnings | (495.6) | (399.7) | (267.2) | (172.2) | (135.6) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (503.2) | 0 | 0 |
| Total Equity | 271.6 | 358.7 | 477.0 | 36.1 | 35.5 |
| Total Liabilities and Equity | 298.2 | 391.5 | 503.2 | 40.6 | 37.4 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 141.3 | 139.3 | 79.6 | 5.4 | 136.4 |